Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
RECRUITING
NCT05327699
EARLY_PHASE1
Glutamatergic Adaptation to Stress as a Mechanism for Anhedonia and Treatment Response With Ketamine
Sponsor: Emory University
View on ClinicalTrials.gov
Summary
The main purpose of this study is to investigate the effects of ketamine on decision-making and emotion processing in a sample of individuals diagnosed with Major Depressive Disorder (MDD).
Key Details
Gender
All
Age Range
18 Years - 65 Years
Study Type
INTERVENTIONAL
Enrollment
140
Start Date
2022-11-08
Completion Date
2026-12-31
Last Updated
2025-04-20
Healthy Volunteers
Yes
Conditions
Interventions
DRUG
Ketamine
A single intravenous (IV) infusion of ketamine calculated at 0.5mg/kg through an indwelling catheter over a 40-100min period.
OTHER
Placebo
A single intravenous (IV) infusion of saline through an indwelling catheter over a 40-100min period.
Locations (1)
Emory University
Atlanta, Georgia, United States